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Abstract
Background: Studies have shown that Dickkopf-1 (DKK-1) is involved in tumorigenesis. Recently, we found that 9
out of 12 human glioma cell lines had high level of DKK-1 protein while the other 3 had very low or non-
detectable level of DKK-1. The aim of this study is to further examine the function of DKK-1 in glioma cells.
Materials and methods: The glioma cell line SHG44 was obtained from a patient with grade II-III astrocytoma.
SHG44 cells were transfected with a human DKK-1 gene. Transfection of the empty vector pcDNA3.1 was used as
negative control. Sensitivity to BCNU was measured by Annexin-V staining. Expression of bax, bcl-2 and caspase-3
of three groups was determined by immunohistochemistry.
Results: The tranfection was confirmed by PCR, RT-PCR and Western blot. More apoptotic cell death was observed
in the DKK-1 transfected cells, comparing to the non-transfected cells, or cells with empty vector. The expression of
bax and caspase-3 of the SHG44 -DDK-1 increased, whereas the expression of bcl-2 decreased
Conclusion: Our results indicated that DKK-1 has a pro-apoptotic function of in glioma.
Introduction
Dickkopf-1(DKK-1) gene was first discovered in 1998 as a
head formation inducer and an antagonist of Wnt signaling
pathway [1]. In normal tissues of human body, DKK-1
mRNA was highly expressed in placenta and at a very low
level in prostate only [2,3]. Recent studies have revealed the
involvement of DKK-1 protein in tumorigenesis. Its exact
role in tumorigenesis, however, still remains unclear. Several
studies reported that the expression level of DKK-1 in differ-
ent tumors was different and its biological functions were
different as well [4-8]. DDK-1 expression was confirmed in
several cancer cell lines derived from breast and other com-
mon cancers. DDK-1 protein secretion was documented in
breast, prostate and lung cancers, but was negligible in mela-
noma [9]. The DKK-1 concentration was significantly higher
in the serum of lung cancer patients than in that of other
malignant tumor patients or healthy people. The DKK-1
concentration is significantly lower in serum of patients with
gastric cancer, colorectal cancer, ovarian cancer, and cervical
adenocarcinoma compared with healthy people [10]. DKK-1
is a candidate gene for tumor suppressor in glioma and con-
sidered as a serologic and prognostic biomarker.In our
recent study of 12 human glioma cell lines, we found that
the supernatant fluid and lysate of 9 cell lines had high level
of DKK-1 protein and the other 3 had very low level or
non-detectable DKK-1 protein (Zhou et al, unpublished
data). The high level of DKK-1 protein in most glioma cell
lines suggested that DKK-1 may play an important role in
glioma and attracted our intention to further study this
DKK-1’sf u n c t i o ni ng l i o m a .
In this study we constructed a eukaryotic expression
vector of human DKK-1(pcDNA3.1-DKK-1) and stably
transfected the vector into the glioma cell line SHG44,
which had no expression of DKK-1 under normal
growth condition. We found that elevated expression of
DKK-1 increased the sensitivity of SHG44 cells to the
anti-cancer drug BCNU in vitro.
Materials and methods
Construction of expression vector
The 816-base pair human DKK-1 cDNA was amplified
from the RNA of human placenta tissue using reverse
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sequence of sense primer was 5’-CTAGCTAGCACAT-
GATGGCT CTGG-3’ (NHe I enzyme digestion site was
indicated as underline) and antisense primer was 5’-
GGAATTCGTGTCTCTGACAAGTGTG-3’ (EcoR I
enzyme digestion site was indicated as underline). The
PCR reaction (10 μl) contained 1 μlc D N A ,lμl1 0×
buffer (MgCl2), 0.4 mM dNTPs, 1umol primer, 1U
TaqDNA Polymerase. After denaturation at 95°C for 5
min, PCR was performed for 35 cycles (30 s at 95°C, 30
s at 50°C and 30 s at 72°C) and extended at 72°C for 5
min. The linear NHeI-EcoRI fragment containing the
DKK-1 cDNA was subcloned into pcDNA3.1 (Invitrogen
Company), which yielded pcDNA3.1-DKK-1 by T4
ligase (TaKaRa Company). The insertion of DDK-1 in
pcDNA3.1 was confirmed by PCR, restriction enzyme
digestion analysis (NHeI and EcoRI) and DNA
sequencing.
Cell culture
The human glioma cell line SHG44 was established by
our lab in 1984 and has been widely used in China. It
was originally obtained from a patient with grade II-III
astrocytoma (according to World Health Organization).
Cells were cultured in RPMI1640 medium (Giboc Com-
pany) supplemented with 10% fetal bovine serum, 100
IU/ml penicillin and 100 μg/ml streptomycin. Cells were
cultured at 37°C in a humidified atmosphere containing
5% carbon dioxide. The culture medium was changed
every 48 h.
Determination of the optimal concentration of G418
G418 is an aminoglycoside and is commonly used as a
selective agent for the bacterial neo r/kan r genes. The
optimal concentration of G418 for selection of resistance
was determined by the following procedure. SHG44 cells
were plated at the same concentration of 5 × 10
4/well, in
24-well plates containing 2 ml culture medium per well.
G418 (sigma Company) was added to wells at 10 different
concentrations (75, 100, 150, 200, 300, 400, 500, 600, 700,
800 μg/ml). The culture media were changed once per 48
h. The lowest G418 concentration, in which all cell died
after 12-14 days culture, was chosen as the optimal con-
centration for resistance selection.
Transfection of SHG44 cells with pcDNA3.1-DKK-1
For stable transfection of the DKK-1 gene, SHG44 cells
(1 × 10
6 ) were plated in 6-well plates 24 h before trans-
fection. Lipofectamine 2000 (Invitrogen Company) was
used to mediate transfection using 5.0 μg of pcDNA3.1-
DKK-1 vector or 5.0 μg of empty pcDNA3.1 vector as a
control according to the manufacture’s protocol. After
48 h transfection, the cells were selected in media sup-
plemented with G418 (150 μg/ml). The medium was
changed once per 48 h. Non-transfected SHG44 cells
died within two weeks. G418-resistant cells were
selected and named as SHG44-DKK-1. Cells with empty
vector of pcDNA3.1 were named as SHG44-EV.
PCR confirmation of DKK-1 in SHG44 cells
DNA from cells of normal SHG44,S H G 44 -EV, SHG44-
DKK-1 was isolated using a DNA extraction kit (Purege-
netm DNA isolation kit, Gentra systems). A portion of
the DKK-1 gene was used to design the primers. The
upstream primer sequence was 5’-TCACGC-
TATGTGCTGCCCCG-3’ and downstream 5’-TGAGG-
CACAGTCTGATGACCGGA-3’. The expected product
was 223 bp. PCR reaction system (50 μl) was: 3 μl
cDNA, 5 μl1 0×B u f f e r ,4μlM g C 1 2, 1 μld N T P ,1μl
primer, 0.3 μl TaqDNA Polymerase. PCR reaction con-
dition was: an initial denaturation step of 94°C for 7
m i n ,f o l l o w e db y3 0c y c l e so fat h r e e - s t e pp r o g r a mo f
94°C for 30 s, 56°C for 30 s, 72°C for 45 s, and a final
extension step of 72°C for 7 min. All the products were
electrophoresed on the agarose gel.
RT-PCR of DKK-1 mRNA
Analysis of the DKK-1 mRNA expression of the three
groups of cells (normal SHG44,S H G 44-EV and SHG44-
DKK-1) was performed by RT-PCR. Total RNA from cell
lines was isolated using Trizol (Invitrogen Company).
The purity and concentration of total RNA were detected
by UV chromatogram analyzer (Backma Company). The
concentration of RNA was adjusted to 1 μg/μl. b-actin
w a su s e da sa ni n t e r n a lc o n t r o lt oe n s u r eR N Aq u a l i t y
and loading accuracy. Primer sequences were 5’-AGC-
GAGCATCCCCCA AAGTT-3’ (upstream) and 5’-
GGGCACGAA GGCTCATCATT-3’ (downstream). The
predicted product size is 285 bp. The primers for DKK-1
were the same mentioned above. The PCR condition for
DKK-1 and b-actin was the same as described above.
Western blot analysis
The total protein of the three groups of cells (normal
SHG44,S H G 44-EV, SHG44-DKK-1) was extracted
directly in the lysis buffer and the concentration of total
protein was quantified by UV chromatogram analyzer.
50 μg protein was separated using 12% sodium dodecyl
sulfate- polyacrylamide gel (SDS-PAGE). After electro-
phoresis, proteins were transferred from gel to zapon
fibrous membrane and the membrane was blocked by
5% non-fat milk. Monoclonal mouse anti-human DKK-1
antibody (R & D Company) (1:1000 dilution) was
probed. For loading control, membranes were striped
and reprobed with mouse anti-human b-actin antibody
(R&D Company)(1:1000 dilution). Horseradish peroxi-
dase (HRP)-conjugated goat-anti-mouse antibody (Coul-
ter Immunotech Company) were added. Protein bands
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system (Millipore Company).
Apoptosis analysis
Normal SHG44,S H G 44.-EV and SHG44-DKK-1 cells
were incubated in 6-well plates by 1 × 10
6 cells/well) in
medium with or without 50 μMB C N U( M e d i c a lI s o -
topes Company) for 24 hours. Apoptosis was detected
using the Annexin V-FITC Apoptosis Detection Kit
(Jingmei Company). Briefly, cells were harvested and
then resuspended in 1 ml of buffer followed by addition
of 5 μl Annexin V and 10 μl PI. Cells were incubated in
the dark at room temperature for 15 min. Cell death
was determined using a flow cytometer (Backman Com-
pany). Data were obtained and analyzed by CellQuest
software (Largo Company).
Immunohistochemical analysis for bax, bcl-2 and
caspase-3
Normal SHG44,S H G 44.-EV and SHG44-DKK-1 cells
were incubated in 6-well plates by 1 × 10
6 cells/well in
medium with or without 50 μMB C N U( M e d i c a lI s o -
topes Company) for 24 hours. Cells were washed in 0.05
M phosphate-buffered saline (PBS) (pH. 7.4) for 15 min-
utes then fixed in 4% paraformaldehyde for 20 minutes.
Streptavidin/biotin-peroxidase (SP) method was used for
immunohistochemical staining. The primary antibodies,
namely antibodies against bax, bcl-2 and caspase-3
(Wuhan Boster Biological Technology, China), were
diluted at 1:100. PBS was used as control. Labeled cells
was photographed and the integrated optical density
(IOD) was measured using Image pro plus 5.02 (Media
Cybernetics, USA).
Statistical analyses
The difference between controls and treated groups
were analyzed by c
2-test. Differences were considered
significant if P < 0.05. Statistics was performed with
SPSS 13.0 software for Windows (LEAD Technologies,
Chicago, IL, USA).
Results
DKK-1 cDNA amplification and identification of
expression vector
We first designed the primers and amplified the 816 bp
DKK-1 gene from human placenta tissue. The PCR pro-
duct was collected and purified. The purified DKK-1
fragment and pcDNA3.1 vector were digested by NHe I
and EcoR I, followed by ligation with T4 ligase at 16°C
for overnight. The ligated plasmid was transformed into
DH5a strain of E. coli. Single colonies were selected
and PCR amplification confirmed a single band of 816
bp. The plasmids were isolated from DH5a and digested
by NHe I and EcoR I. DNA gel showed two bands, one
corresponding to the 816 bp fragment and the second
one corresponding to the vector pcDNA3.1. DNA
Sequencing showed that the 816 bp fragment matched
with the DNA sequence of DKK-1 gene.
Cell morphology and SHG44-DKK-1 screening
Normal SHG44 cells were usually elongated and football
shaped (Fig.1a). They died within two weeks when cul-
tured in the presence of 150 μg/ml G418 (Fig.1b). Cells
transfected with pcDNA3.1-DKK-1 were resistant to
G418 and were screened under G418 for about three
weeks and named as SHG44-DKK-1. The SHG44-DKK-1
cells appeared similar to the non-transfected cells and
sometimes formed clusters (Fig.1c, d).
PCR analysis of DKK-1 in SHG44 cells
DNA was extracted from cells of normal SHG44, SHG44-
EV and SHG44 -DKK-1. The extracted DNA was ampli-
fied by PCR using the primer pair described above. As
expected, a 223bp fragment was observed in SHG44
Figure 1 Microscopic images of different groups cells in selection. Normal SHG44 (1a), normal SHG44 cells cultured in the presence of G418
for two weeks (1b); and SHG44-DKK-1 cells cultured in the presence of G418 for three weeks (1c, 1d).
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cells (Fig.2). This result further confirmed the specific
transfection of DKK-1 gene into the SHG44 cells.
DKK-1 mRNA expression in SHG44 cells
RNA extracted from normal SHG44, SHG44-EV and
SHG44 -DDK-1 cells was amplified by RT-PCR and sub-
sequently analyzed by DNA gel. A prominent 223 bp
band was detected from SHG44 -DKK-1 cells, but non-
detectable from SHG44 -EV cells or normal SHG44 cells
(Fig.3).
DKK-1 protein expression in SHG44 cells
The total protein exacted from normal SHG44,S H G 44-
EV and SHG44 -DDK-1 cells was separated using 12%
SDS-PAGE and was subsequently analyzed by Western
blot. A 35KD band, which corresponds to the size of
DKK-1 protein was observed in SHG44 -DKK-1 cells,
but not in SHG44 -EV or normal SHG44 cells (Fig.4).
BCNU induced apoptosis
BCNU is an anti-cancer drug and an inducer of apopto-
tic cell death. We used BCNU to further assess the role
of DKK-1 in SHG44 cells. Apoptosis was observed in all
three groups of cells: normal SHG44,S H G 44-EV and
SHG44 -DDK-1. The average apoptosis ratio of normal
SHG44 ,S H G 44-EV cells and SHG44 -DKK-1, was2.5 ±
0.2%, 1.8 ± 0.2%, 8.4 ± 0.3%, respectively(Fig.5). The
apoptosis ratio of SHG44 -DKK-1 cells was significantly
(P < 0.05) higher than that of normal SHG44 or SHG44-
EVcells. Minimal apoptosis was observed in all three
groups of cells in the absence of BCNU.
Immunohistochemistry analysis
Images of bax, caspase-3 and bcl-2 staining are shown in
Figure 6. The positive reaction located in cytosol was
stained in brown. The color of the stain is positively
correlated to the protein expression. The IOD of each
group revealed that in the SHG44 -DDK-1 the expres-
sion of bax and caspase-3 increased, whereas the expres-
sion of bcl-2 decreased (Table 1).
Discussion
The family of DKK genes is a small, but conservative
gene family, which is composed of DKK-1, DKK-2,
DKK-3, DKK-4 and DKKL-1 (also called Soggy), a DKK-
3 related gene. DKK proteins possess different structure
and function, but many of them play important roles in
various human diseases [2]. DKK-1 is the most well-stu-
died gene in the DKK gene family. It is mapped to chro-
mosome 10q11.2 [11] and encodes a secretory
glucoprotein, which contains 266 amino acids with a
molecular weight of 35KD. The glucoprotein contains a
N-terminal signal peptide of 31 amino acids, two con-
served cysteine-rich domains and a C-terminus with gly-
cosylation function. DKK-1 acts as a wnt antagonist by
forming a complex with the transmembrane proteins
Kremen1 and 2 (Krm1/2) and low- density-lipoprotein
5/6(LRP5/6). The complex is then removed through
endocytosis, resulting in the removal of LRP5/6 from
the cell surface [12,13] Recent studies revealed that
DKK-1 is not only an antagonist of classic Wnt/b-cante-
nin signaling pathway but also a direct regulator of tran-
scription of its target genes [14].
Figure 2 PCR amplification of DKK-1 SHG44-DKK-1 cells was
lane 1, SHG44-EV was lane 2, normal SHG44 cells was lane 3
and control (culture medium only) was lane 4. M was the
marker for standard DNA molecular mass.
Figure 3 RT-PCR analysis of DKK-1 mRNA expression. Lane 1, 3
and 5 b-actin from cells of SHG44-DKK-1, SHG44-EV and normal
SHG44 respectively. Lane 2, 4, 6 were DKK-1 mRNA from cells of
SHG44-DKK-1, SHG44-EV and normal SHG44 respectively. M was the
marker of standard DNA molecular mass.
Figure 4 Western blot analysis of DKK-1 protein. It showing
DKK-1 protein from cells of normal SHG44 (lane 1), SHG44-EV (lane 2)
and SHG44-DKK-1 (Lane 3). b-actin was used as loading control.
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shown to be complicated and even controversial. A
number of studies showed that DKK-1 induces apopto-
sis and inhibits tumor growth [15-17] DKK-1 expression
in primary medulloblastoma cells is significantly down-
regulated relative to normal cerebellum and transfection
of a DKK-1 gene construct into D283 cell line sup-
presses medulloblastoma tumor growth [18]. In addi-
tion, adenoviral vector-mediated expression of DKK-1 in
medulloblastoma cells significantly increases the
Figure 5 Apoptosis ratio was detected by flow cytometry analysis. Representative image of flow cytometry analysis of BCNU treated cells,
showing the apoptosis ratio (right lower-quadrant) of normal SHG44 (a), SHG44-EV (b) and SHG44-DKK-1 (c) cells.
Figure 6 Bax, bcl-2 and caspase-3 protein expression inthree groups cell (×400). (A) Bax normal SHG44;(B)Bax SHG44-EV; (C)Bax SHG44-DKK-
1;(D) Bcl-2 normal SHG44 (E)Bcl-2 SHG44-EV; (F)Bcl-2 SHG44-DKK-1; (G)Caspase-3 normal SHG44; (H)Caspase-3 SHG44-EV; (I)Caspase-3 SHG44-DKK-1.
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overexpressed in tissues and serum of lung cancers and
esophageal squamous cell carcinoma, suggesting that
DKK-1 may act as pro-oncogene [19]. Differential gene
expression analysis showed that the resistance of the
CAL27 cell line to cisplatin, an anti-cancer chemother-
apy drug, is associated with the expression level of
DKK-1 [20]. The expression level of DKK-1, an inhibitor
of canonical WNT signaling, was decreased in Cal27cis,
a sub-cell line of Cal27, and was obtained by treating
Cal27 with increasing concentrations of cisplatin. Over-
expression of DKK-1 in both Cal27 and Cal27cis
resulted in increased sensitivity to cisplatin, suggesting
DKK-1 and the WNT signaling pathway as a marker
and target for cisplatin chemosensitivity.
In human glioma cells, a previous study showed that
transfection of DKK-1into human glioma cell line
U87MG causes the cells more sensitive to cisplatin and
alkylating agent [15]. Our current study revealed that
the expression of bax and caspase-3 increased, whereas
the expression of bcl-2 decreased in the SHG44 -DDK-1
cells, further confirming the pro-apoptosis function of
DKK-1. We speculate that the function of DKK-1 may
be tissue or cell type specific. Another possibility is that
mutations of DKK-1 could be the causes of different
functions of DKK-1. A screening of 73 brain tumors,
however, revealed that no obvious mutations of DKK-1
were found in these brain tumors [21]. More studies,
especially direct comparison of DKK-1 in different cell
types at the same condition, are needed in order to bet-
ter understand the complex functions of DKK-1 in rela-
tion to cancer development.
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